Bladder Cancer
Hyperthermic intravesical chemotherapy with mitomycin-C for the treatment of high-risk non-muscle-invasive bladder cancer patients.
April 11, 2023
Urinary Neuroendocrine Neoplasms Treated in the "Modern Era": A Multicenter Retrospective Review.
April 11, 2023
Insurance type and area deprivation are associated with worse overall mortality for patients with muscle-invasive bladder cancer.
April 10, 2023
The Urinary Microbiome and Bladder Cancer.
April 7, 2023
Ipilimumab and Nivolumab Treatment in Patients With Stage III Urothelial Cancer - Expert Commentary
April 6, 2023
Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging.
April 6, 2023
Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer.
April 6, 2023
Optimizing surgical outcomes in bladder cancer patients undergoing radical cystectomy.
April 5, 2023
Multi-omics Analysis for Prediction of Survival in Bladder Cancer Patients - Expert Commentary
April 4, 2023
Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary Centers.
April 4, 2023